The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

Nature Medicine

Volumn 17, Issue 2, 2011, Pages 211-216

  Liu, Can ^a,b   Kelnar, Kevin ^c   Liu, Bigang ^a,b   Chen, Xin ^a   Calhoun Davis, Tammy ^a   Li, Hangwen ^a   Patrawala, Lubna ^b   Yan, Hong ^a   Jeter, Collene ^a   Honorio, Sofia ^a   Wiggins, Jason F ^c   Bader, Andreas G ^c   Fagin, Randy ^d   Brown, David ^c   Tang, Dean G ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c SYNLOGIC   (United States)

^d Hospital at Westlake   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; MICRORNA; MIR 34A; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER STEM CELL; CLONOGENESIS; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TUMOR XENOGRAFT;

ANIMALS; ANTIGENS, CD44; GENE EXPRESSION REGULATION, NEOPLASTIC; MALE; MICE; MICRORNAS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MUS;

EID: 79751473114     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.2284     Document Type: Article

References (39)

1. Visvader, J.E. & Lindeman, G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8, 755-768 (2008).
2. Croce, C.M. & Calin, G.A. miRNAs, cancer, and stem cell division. Cell 122, 6-7 (2005). (Pubitemid 40977933)
3. Melton, C., Judson, R.L. & Blelloch, R. Opposing microRNA families regulate self-renewal in mouse embryonic stem cells. Nature 463, 621-626 (2010).
4. Yu, F. et al. let-7 regulates self-renewal and tumorigenicity of breast cancer cells. Cell 131, 1109-1123 (2007). (Pubitemid 350235025)
5. Shimono, Y. et al. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 138, 592-603 (2009).
6. Esquela-Kerscher, A. & Slack, F.J. Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269 (2006).
7. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J. & Clarke, M.F. Prospective identifcation of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100, 3983-3988 (2003). (Pubitemid 36418143)
8. Li, C. et al. Identifcation of pancreatic cancer stem cells. Cancer Res. 67, 1030-1037 (2007).
9. Prince, M.E. et al. Identifcation of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 104, 973-978 (2007). (Pubitemid 46154721)
10. Dalerba, P. et al. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. USA 104, 10158-10163 (2007). (Pubitemid 47175279)
11. Du, L. et al. CD44 is of functional importance for colorectal cancer stem cells. Clin. Cancer Res. 14, 6751-6760 (2008).
12. Zeilstra, J. et al. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis. Cancer Res. 68, 3655-3661 (2008).
13. Yang, Z.F. et al. Signifcance of CD90+ cancer stem cells in human liver cancer. Cancer Cell 13, 153-166 (2008). (Pubitemid 351163165)
14. Takaishi, S. et al. Identifcation of gastric cancer stem cells using the cell surface marker CD44. Stem Cells 27, 1006-1020 (2009).
15. Chan, K.S. et al. Identifcation, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc. Natl. Acad. Sci. USA 106, 14016-14021 (2009).
16. Zhang, S. et al. Identifcation and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 68, 4311-4320 (2008).
17. Collins, A.T., Berry, P.A., Hyde, C., Stower, M.J. & Maitland, N.J. Prospective identifcation of tumorigenic prostate cancer stem cells. Cancer Res. 65, 10946-10951 (2005). (Pubitemid 41713363)
18. + prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25, 1696-1708 (2006).
19. + cell population is enriched in tumor-initiating cells. Cancer Res. 67, 6796-6805 (2007). (Pubitemid 47105527)
20. He, L. et al. A microRNA component of the p53 tumour suppressor network. Nature 447, 1130-1134 (2007). (Pubitemid 47014436)
21. Raver-Shapira, N. et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 26, 731-743 (2007). (Pubitemid 46856247)
22. Chang, T.C. et al. Transactivation of miR-34a by p53 broadly infuences gene expression and promotes apoptosis. Mol. Cell 26, 745-752 (2007).
23. Bommer, G.T. et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 17, 1298-1307 (2007). (Pubitemid 47176893)
24. Tarasov, V. et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6, 1586-1593 (2007). (Pubitemid 47327945)
25. Johnson, C.D. et al. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res. 67, 7713-7722 (2007). (Pubitemid 47281364)
26. Wiggins, J.F. et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res. 70, 5923-5930 (2010).
27. Jeter, C.R. et al. Functional evidence that the self-renewal gene NANOG regulates human tumor development. Stem Cells 27, 993-1005 (2009).
28. - cancer cells are similarly tumorigenic. Cancer Res. 65, 6207-6219 (2005). (Pubitemid 40994406)
29. Bhatia, B. et al. Critical and distinct roles of p16 and telomerase in regulating the proliferative lifespan of normal human prostate epithelial progenitor cells. J. Biol. Chem. 283, 27957-27972 (2008).
30. Li, H.W. et al. Methodologies in assaying prostate cancer stem cells. Methods Mol. Biol. 568, 85-138 (2009).
31. Hermeking, H. The miR-34 family in cancer and apoptosis. Cell Death Differ. 17, 193-199 (2010).
32. Li, H., Chen, X., Calhoun-Davis, T., Claypool, K. & Tang, D.G. PC3 Human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res. 68, 1820-1825 (2008). (Pubitemid 351416567)
33. Dontu, G. et al. In vitro propagation and transcriptional profling of human mammary stem/progenitor cells. Genes Dev. 17, 1253-1270 (2003). (Pubitemid 36583168)
34. Yamakuchi, M., Ferlito, M. & Lowenstein, C.J. miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. USA 105, 13421-13426 (2008).
35. Li, Y. et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 69, 7569-7576 (2009).
36. Miranda, K.C. et al. A pattern-based method for the identifcation of microRNA-target sites and their corresponding RNA/RNA complexes. Cell 126, 1203-1217 (2006). (Pubitemid 44380294)
37. Godar, S. et al. Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression. Cell 134, 62-73 (2008). (Pubitemid 351905743)
38. Jin, L., Hope, K.J., Zhai, Q., Smadja-Joffe, F. & Dick, J.E. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat. Med. 12, 1167-1174 (2006). (Pubitemid 44527352)
39. Ji, Q. et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS ONE 4, e6816 (2009).